Jci_page_head_homepage_01 Jci_page_head_homepage_02
Dan Ma, Julian P.H. Shield, Wendy Dean, Isabelle Leclerc, Claude Knauf, Rémy Burcelin, Guy A. Rutter, Gavin Kelsey
Published in Volume 114, Issue 3
J Clin Invest. 2004; 114(3):339–348 doi:10.1172/JCI19876
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 5

Glucose and insulin tolerance in TNDM29 mice. Glucose tolerance tests (AC): glucose concentration determined in whole blood at the indicated times following intraperitoneal injection of glucose in neonate (A), juvenile (B), and adult (C) TNDM29 and wild-type mice. Serum insulin concentrations (DF) at the indicated time points of the glucose tolerance test in neonates (D), juveniles (E), and adults (F). Insulin tolerance tests (GI): glucose concentration determined in whole blood at the indicated times following intraperitoneal injection of insulin in neonates (G), juvenile (H), and adult (I) TNDM29 and wild-type mice. Euglycemic hyperinsulinemic clamp studies in TNDM29 and wild-type mice (J): whole-body glucose turnover rate (TO), whole-body glycolysis rate (Glycol) and whole-body glycogen synthesis (GlnSynth) during the test are shown. All results are expressed as mean ± SEM (n = 12–20, in more than 3 separate experiments, except for the clamp studies, where n = 5–6). *P < 0.05, **P < 0.01 transgenic versus control group by unpaired, two-tailed Student’s t test and Mann Whitney U test, as appropriate.